Beranda › Kanker Kandung Kemih › New York › Buffalo
Uji klinis Kanker Kandung Kemih di Buffalo, NY
5 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar Buffalo (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Menerima pesertaFase 3
- Roswell Park Cancer Institute, Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- Roswell Park Cancer Institute IDS, Buffalo
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 2
- Roswell Park Comprehensive Cancer Center, Buffalo
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Menerima pesertaFase 1/2
- Roswell Park Cancer Institute, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Buffalo
Uji klinis Kanker Kandung Kemih di kota lain
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Boston, MA26 studi
- Washington, DC26 studi
- Los Angeles, CA24 studi
- Baltimore, MD24 studi
- St. Louis, MO22 studi
- Philadelphia, PA21 studi
- Seattle, WA21 studi
- Edison, NJ21 studi
Studi lain di Buffalo
- Kanker (semua jenis)19 studi
- Leukemia Mieloid Akut19 studi
- Kanker Paru Non-Sel Kecil18 studi
- Kanker Paru16 studi
- Kanker Payudara16 studi
- Kanker Ovarium13 studi
- Kanker Prostat11 studi
- Kanker Metastatik11 studi
- Mieloma Multipel10 studi
- Melanoma10 studi
- Obesitas9 studi
- Limfoma Burkitt8 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.